Downregulation of enhancer RNA EMX2OS is associated with poor prognosis in kidney renal clear cell carcinoma
Figure 3.Kaplan–Meier survival analysis of EMX2OS expression according to age, gender, stage, and grade stratification. (A) Age ≤ 60 years and age > 60 years. (B) Male and female. (C) Stage I/II and stage III/IV. (D) Grade 1/2 and grade 3/4.